about
Pharmacokinetics of chewed vs. swallowed raltegravir in a patient with AIDS and MAI infection: some new conflicting data.HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans.Mortality Risk for Acute Cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitisAcute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report.Nonmelanoma skin cancer in mountain guides: high prevalence and lack of awareness warrant development of evidence-based prevention tools.Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study.Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results.Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting.Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study.Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study.Impact of Gliding on the Prevalence of Keratinocyte Carcinoma and its Precursors: A Cross-sectional Study Among Male Pilots in Bavaria.PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient.Alopecia syphilitica diffusa.Fungal "colonisation" is associated with increased mortality in medical intensive care unit patients with liver cirrhosis.Severe hydrocarbon pneumonitis in African refugees after fuel ingestion.Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.Addiction: an underestimated problem in psoriasis health care.Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study.[Infectiological Rapid Tests in Practices and at Home].2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV.Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study.Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: The TAF-IR StudyMonthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort StudyPrediction of 28-day mortality by indocyanine green disappearance rate, other markers of hepatic function and transpulmonary thermodilution parameters: a prospective study in 154 patientsPrimary skin manifestation of plasmoblastic lymphoma in an AIDS patient with long-term survivalDie PrEP schützt — wenn sie sachgerecht eingesetzt wirdVor- und Nachteile in der modernen ARTOphthalmologische Veränderungen im Rahmen der Erstdiagnose einer HIV-InfektionA retrospective clinical and microbial analysis of 32 patients with bilomasCost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016Primary and secondary prevention of skin cancer in mountain guides: attitude and motivation for or against participationStrongyloides stercoralis hyperinfection syndrome presenting as mechanical ileus after short-course oral steroids for chronic obstructive pulmonary disease (COPD) exacerbationStrategies for increasing diagnostic yield of community-onset bacteraemia within the emergency department: A retrospective studyClinical management of ageing people living with HIV in Europe: the view of the care providersInfluence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV[General practitioners contribution to sexual health]Are 96-week data enough for doravirine to DRIVE FORWARD?[Ancient and modern plagues: Sexual transmitted diseases (STD)]
P50
Q30884873-700480C5-6711-4231-ADAA-6FB174E8FCB8Q34673978-97904848-81F2-45FA-9AF1-C97D15EBDB6DQ35918775-CDF8F817-80F0-4253-BB45-8BBC9181463AQ37370370-50878B8D-80BF-407B-ACA0-0FBFED11C252Q38786692-24235E41-8DA9-498E-83CA-7B589157F899Q38844898-5FC2B459-44C4-453A-8AA7-A4A50DCF997AQ39428524-EC3B69A9-9083-4433-B91C-81D0C10EEA02Q39987031-CBF3E8C8-1278-4237-87BC-CF5F6F01238EQ40072239-35DC7648-8DA6-40F1-85CD-38047FF25718Q40393165-0A4419AA-79F2-4468-915C-4C2384317CD4Q40465242-8EAB4D45-9F08-4692-BC14-823FC483BD8CQ40679634-743CB938-9E57-4ACB-A2A8-F5D58F6DE064Q41183328-EF9A8F65-8F5D-42D2-A2E5-CA09EBD8FB06Q41269261-737DE155-735A-4809-B683-7212096CA92BQ41687167-C084352D-0A67-4E3B-A6AB-99E80254AAF1Q44725002-7E9B3A61-FD30-44F0-85F7-02A07ED85AEFQ47136520-B5C3E0D0-877A-427F-99B6-3A1B382F902EQ47420952-7715F9B6-30D7-4984-945A-C0087E3D5757Q49824478-B0278F7B-93E9-4A6B-B731-B1BC97A59211Q50160494-AB6D1A15-0260-4A95-93D6-9D60C1425089Q51417343-CCA3B6C6-8FF6-4459-9F7A-DE397EC5636CQ53790963-AFC9BC60-E054-4220-B571-CF5F0213127CQ57033518-5E57742B-B34A-48E2-AB41-B8F8AB28AF7DQ58770234-E40F8C09-EB80-47FD-A976-FD592A440628Q59923221-13CC1746-ACCD-4549-A6BF-985AAC144817Q60609680-7A9CCA80-0BFF-4777-95A1-1BEBDEB061FBQ60609681-50436733-D8E9-430F-BF58-C8C4CA9C3977Q60609682-78AAE58F-82E0-4B3A-83E6-6E35CE91BF1DQ60609684-E7A2A60D-0888-4D98-B2DC-95F06BFBB3CFQ64075161-BB6EE6A6-631C-42A3-840D-3250D03A589FQ64259892-80E16F5E-B319-477F-BC07-04CF0FE1575CQ88537911-E06780BF-5312-4328-A2A5-EDD63950D930Q88918155-69FF0C9D-C65C-42F8-8982-3B55CA41C740Q89841221-4658B8AD-A4EA-4B6E-9978-D234E47E6FC2Q90076974-E5624E2F-FD2A-47F2-9D13-3A94275D08D3Q90550717-959A6DC4-ECB9-4AC7-92E7-5739AEE1CB15Q90685342-D5303518-E7C6-4357-B9DE-D894BEC68C71Q90717022-849C4108-EE1D-4302-88E9-2ECE6F8226B1Q91328404-DDFDE94B-32A2-4709-A78B-349B1D2C23C3Q91696973-22C6EBD0-F41D-4938-8189-9554FAF7E38F
P50
description
researcher ORCID ID = 0000-0002-3875-5367
@en
wetenschapper
@nl
name
Christoph Spinner
@ast
Christoph Spinner
@en
Christoph Spinner
@es
Christoph Spinner
@nl
type
label
Christoph Spinner
@ast
Christoph Spinner
@en
Christoph Spinner
@es
Christoph Spinner
@nl
prefLabel
Christoph Spinner
@ast
Christoph Spinner
@en
Christoph Spinner
@es
Christoph Spinner
@nl
P21
P214
158144647642041197465
P31
P496
0000-0002-3875-5367
P734
P735
P7859
viaf-158144647642041197465